The short answer
- Is it FDA approved? Not for joint, back, or other orthopedic pain. The handful of approved stem cell products are all for blood cancers, blood disorders, and transplant complications (see the list).
- Is it legal? Physicians can legally offer some procedures, and Florida passed a 2025 law allowing certain unapproved stem cell therapies for orthopedic conditions, wounds, and pain. Marketing unapproved products can still break federal law, and state laws don't make a treatment FDA-approved.
- Is it safe? Generally considered low-risk with qualified physicians and properly processed cells, but not risk-free. The FDA has warned that some patients have been seriously harmed by unproven products.
For orthopedic and pain conditions, stem cell therapy is not FDA approved. Most regenerative applications for pain are investigational: the evidence is still developing, and no product is approved for those uses. That doesn't make them automatically unsafe or illegal, but it does mean you should approach them carefully and well informed. This guide explains what the FDA has approved, the legal picture (including new state laws), the safety risks, and exactly what to ask a clinic.
Key takeaways
- Every FDA-approved stem cell product is for a blood cancer, blood disorder, or transplant complication: cord blood products, Omisirge, Ryoncil (December 2024), and Tregzi (June 2026). None are approved for orthopedic conditions.
- There are currently no FDA-approved exosome products.
- Most stem cell, PRP, and other regenerative uses for pain are investigational and not FDA-approved for those uses.
- Procedures are generally considered low-risk with qualified providers, but no procedure is risk-free, and unapproved products add risk.
- Provider quality, honest expectation-setting, and transparent cell sourcing matter enormously.
What the FDA has — and hasn't — approved
The U.S. Food & Drug Administration regulates stem cell products, and generally all stem cell products require FDA approval. Every approved product that is or contains stem cells is for a blood cancer, a blood or immune disorder, or a transplant complication. None is approved for joint, back, or any other orthopedic use.
| Product | What it is | Approved for | Approved |
|---|---|---|---|
| Cord blood products (9 licensed, including Hemacord, Ducord, Allocord, Clevecord and Regenecyte) | Blood-forming stem cells from donated umbilical cord blood | Transplants for disorders affecting blood production | 2011 onward |
| Omisirge (omidubicel) | Processed cord blood stem cells | Blood cancers when a cord blood transplant is planned; later also severe aplastic anemia | April 2023 |
| Ryoncil (remestemcel-L) | Donor bone-marrow mesenchymal stromal cells (MSCs), given by IV | Children with steroid-refractory acute graft-versus-host disease, a transplant complication | December 2024 |
| Tregzi | Donor blood stem cells combined with regulatory T cells | Adults with blood cancers having a matched-donor stem cell transplant | June 2026 |
| Gene therapies such as Zynteglo, Casgevy and Lyfgenia | A patient's own blood stem cells, genetically modified | Inherited blood disorders such as beta thalassemia and sickle cell disease | 2022 onward |
Source: FDA, Approved Cellular and Gene Therapy Products (content current as of September 17, 2026). The FDA classifies the gene therapies as gene therapies rather than stem cell products. Checked October 6, 2026.
Ryoncil matters because MSCs are the same cell type most orthopedic clinics talk about. Its approval shows the FDA will approve an MSC product when there's evidence for a specific use. It does not make MSC injections approved for knees or backs. (The FDA's consumer page, last updated in April 2024, still describes cord blood products as the only approved stem cell products; it predates Ryoncil and Tregzi.)
The FDA's consumer alert on stem cells for orthopedic conditions
In its July 2020 Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes, the FDA warned that these products are not approved for orthopedic conditions, and it repeats that warning on its current patient information page. In plain terms: no stem cell or exosome product is FDA-approved for osteoarthritis, tendonitis, disc disease, tennis elbow, or back, hip, knee, neck, or shoulder pain.
The FDA has also stated that there are currently no approved exosome products, and that regenerative products such as stem cells, exosomes, adipose-derived products, Wharton's jelly, umbilical cord blood, and amniotic fluid have not been approved to treat orthopedic conditions — including osteoarthritis, tendonitis, disc disease, tennis elbow, or back, hip, knee, neck, and shoulder pain. The FDA has repeatedly cautioned consumers about clinics marketing unapproved stem cell products. You can review the FDA's consumer guidance on stem cell therapies directly.
Is stem cell therapy for back pain FDA-approved?
No. The FDA names disc disease and back and neck pain among the orthopedic conditions that no regenerative product has been approved to treat. That covers injections into a spinal disc or facet joint using bone marrow concentrate, fat-derived cells, umbilical cord or Wharton's jelly products, or exosomes. These are investigational. If a clinic offers one, ask what exactly is being injected and why it's recommended over standard care. For what spine treatments cost, see our stem cell therapy cost guide.
"FDA-approved" vs. "FDA-registered" vs. "FDA-cleared"
Clinic marketing often uses FDA language that sounds like approval but isn't:
- FDA-approved means the FDA reviewed evidence of safety and effectiveness for a specific use and licensed the product for that use. No stem cell product is approved for orthopedic conditions.
- FDA-registered means a lab or facility has registered with the FDA and lists the products it handles. Registration is a requirement for operating, not a review of whether the treatment works. "Processed in an FDA-registered lab" tells you about the facility, not the treatment.
- FDA-cleared usually applies to devices, such as some PRP preparation systems. Clearance of a device does not mean the treatment made with it is approved for your condition.
If a clinic describes a stem cell treatment for knee, back, or shoulder pain as "FDA-approved," that's a red flag. If it says "FDA-registered lab," ask what that does and doesn't mean.
Is stem cell therapy legal?
Some stem cell procedures are legal in the U.S., but none is FDA-approved for joint, back, or other orthopedic pain. Legal and FDA-approved are different questions. In short: physicians can legally offer some regenerative procedures, but marketing an unapproved product to treat a disease can violate federal law, and the FDA has taken enforcement action against clinics that did so. Procedures that use your own tissue with minimal processing, for the same basic function it had in your body, may be regulated differently from manufactured drug products. The line is technical, and clinics don't always stay on the right side of it.
State laws: Florida and Texas
Some states have passed their own stem cell laws. These change what state medical regulators allow. They do not change FDA approval status or override federal law.
- Florida (SB 1768, effective July 1, 2025). Allows licensed physicians to use certain stem cell therapies that are not FDA-approved for orthopedic conditions, wound care, and pain management, within their scope of practice. The cells must come from facilities that are FDA-registered and accredited by specific organizations, embryonic and fetal cells are excluded, and patients must sign a consent form covering benefits and risks. Advertising must include a notice that the therapy has "not yet been approved" by the FDA. Legal analysts have noted the law conflicts with federal requirements (Holland & Knight).
- Texas (HB 810, 2017). Allows patients with a severe chronic disease or terminal illness to access investigational stem cell treatments that are being studied in clinical trials but aren't yet FDA-approved, on a physician's recommendation and with written consent. It is narrower than it's often marketed: it isn't a general permission for any clinic to sell stem cell injections for joint pain (Matthews et al., Stem Cells Dev 2018).
If you live in one of these states, a clinic may tell you the treatment is "legal here." That can be true under state law and still say nothing about whether the treatment works, or whether it's FDA-approved. See our Florida and Texas guides for state-specific details.
Why clinics still offer it: "investigational" vs. "approved"
If most orthopedic uses aren't approved, why are clinics everywhere offering them? The honest answer is that there is a wide gap between how these treatments are marketed and what the FDA has actually approved. Some procedures that use a patient's own minimally manipulated tissue may be regulated differently from manufactured drug products, but the FDA has been clear that many stem cell and regenerative products marketed for orthopedic conditions are unapproved and that their safety and effectiveness have not been established for those uses.
The FDA has sent dozens of warning and untitled letters to clinics and suppliers over these products. Our FDA warning letter tracker lists 85 of them since 2019, searchable by company, state, and product type, with a link to each letter.
The key word is investigational. It does not mean illegal, and it does not mean worthless — it means unproven for that use. For patients, that distinction is the whole game: it's reasonable to consider an investigational option with a qualified physician, but it should be a careful, eyes-open decision, not a response to a guaranteed-cure advertisement.
Where PRP fits in the regulatory picture
Platelet-rich plasma (PRP) sits in a slightly different spot. PRP is prepared from your own blood, and some PRP preparation devices are FDA-cleared — but the FDA has not approved PRP as a treatment for orthopedic pain, hair loss, or skin rejuvenation. In practice, that means orthopedic PRP is investigational, hair-loss PRP is off-label, and aesthetic PRP is cosmetic. For a full breakdown, see our guide to PRP therapy and our hub on PRP for hair loss.
Is Wharton's jelly or umbilical cord stem cell therapy FDA approved?
No, not for joints or pain. Umbilical cord tissue, Wharton's jelly, cord blood, and amniotic products are among the most heavily marketed options. The FDA lists all of them among the regenerative products that have not been approved to treat orthopedic conditions. The only approved cord-derived products are the cord blood products for blood disorders described above. That's a different use, prepared and given in a different way. If a clinic offers an umbilical cord injection for a joint, ask exactly what product it is, who makes it, and whether it contains living cells. Many don't, even when they're marketed as "stem cells."
Are "stem cell patches" FDA approved?
No. Skin patches sold online as "stem cell patches" don't contain stem cells; they're marketed as ways to "activate" your own. No patch has been approved by the FDA to treat any disease or regenerate tissue. If a patch is listed with the FDA at all, that's a product listing, not a review of whether it works.
Want help finding a credible, board-certified provider?
Take a 2-minute assessment and we'll match you with a verified clinic near you — one that frames treatment honestly. Free, no obligation.
Take the Free AssessmentWhen will stem cell therapy be FDA approved for joints?
No one can give a date. No stem cell product is FDA-approved for any orthopedic condition, and approval depends on evidence that doesn't exist yet. To get there, a company has to show in clinical trials, usually including large randomized ones, that one specific product is safe and works for one specific condition. Then the FDA has to review and license it.
Even then, the approval would cover that one product for that one use, not "stem cell therapy" in general. Ryoncil shows how narrow that can be: it's approved only for children with one transplant complication. Some products in testing get a Regenerative Medicine Advanced Therapy (RMAT) designation, which can speed up the FDA's review. That designation is not an approval.
To see what's being tested right now, search ClinicalTrials.gov. If a clinic tells you approval is "coming soon," ask which product, which trial, and which trial phase.
What the evidence actually shows
"Not FDA approved" is not the same as "no evidence." Research into regenerative medicine is active and growing — thousands of studies are indexed on PubMed, and hundreds of trials are listed on ClinicalTrials.gov. The strongest signal to date is for the knee: a 2021 meta-analysis of nine randomized controlled trials of stem cell therapy for knee osteoarthritis reported improvements in some pain and function scores. As the authors of such reviews consistently emphasize, study designs vary, sample sizes are often small, and larger, longer-term trials are still needed before firm conclusions can be drawn. For a fuller, sourced review, see our MSC research for orthopedic pain pillar and our complete guide to stem cell research.
Is stem cell therapy safe?
When performed by qualified, board-certified providers using appropriately sourced and processed cells, regenerative procedures are generally considered low-risk — but no medical procedure is risk-free. Risks and benefits vary by individual and by the specific product used, and they should be discussed with a licensed physician. Sourcing matters: reputable clinics use biologics processed in FDA-registered laboratories with rigorous screening, while unapproved or improperly processed products carry added risk.
Reported risks and side effects
- Infection at the injection site, particularly with improperly handled products.
- Immune or allergic reactions, more likely with products not derived from your own tissue.
- Bleeding, swelling, or pain at or around the injection site.
- Harm from unapproved or contaminated products — the FDA has warned that some patients have been seriously harmed by unproven stem cell treatments.
- Financial harm and false hope from clinics promising results the evidence doesn't support.
Red flags when evaluating a clinic
Because protocols aren't standardized and quality varies, knowing the warning signs protects you:
- Promises of a guaranteed cure or "miracle" results.
- Claims that a treatment "regrows cartilage" or is "FDA approved" for orthopedic pain.
- High-pressure sales tactics, large up-front payments, or financing pushed before evaluation.
- Vague or evasive answers about cell sourcing, processing, and FDA-registered labs.
- No board-certified physician performing the evaluation and procedure.
Questions to ask before any treatment
Turn your consultation into a screening tool. Bring these questions:
- Is this treatment FDA-approved or investigational for my specific condition?
- What exactly is being injected, and where is it sourced and processed? Is the lab FDA-registered?
- What are the realistic expected outcomes — and what does the evidence say for my condition?
- What are the risks and side effects, and how do you handle complications?
- Who performs the procedure, and what are their credentials?
- What is the total cost, and what happens if it doesn't work?
This is exactly where Regenerative Treatment Guide helps: rather than steering you to any single clinic, we match you with verified, board-certified providers based on your condition and location, so you can have an informed conversation. You can also explore treatment availability by state on our locations hub. For a step-by-step checklist of where to verify a clinic before you call it, see how to choose a stem cell clinic.
Frequently asked questions
Get matched with a verified provider
See if you may be a candidate and connect with a board-certified clinic near you — free, no obligation.
Take the Free AssessmentKeep reading
- FDA warning letters to stem cell clinics: searchable tracker
- How to Choose a Stem Cell Clinic: 6 Checks You Can Do Yourself
- Stem Cell Research: The Complete Guide
- MSC Research for Orthopedic Pain (2026 Update)
- Conditions Regenerative Medicine May Help Address
- Stem Cell Therapy for Knee Pain
- Stem Cell Therapy for Shoulder Pain
- Stem Cell Therapy for Hip Pain
- Stem Cell Therapy for Arthritis & Osteoarthritis
- Stem Cell Therapy for Neuropathy
- How Much Does Stem Cell Therapy Cost?
- Find Stem Cell Therapy by State